Next Article in Journal
Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study
Previous Article in Journal
68Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
 
 
Review

Article Versions Notes

Pharmaceuticals 2021, 14(5), 449; https://doi.org/10.3390/ph14050449
Action Date Notes Link
article pdf uploaded. 10 May 2021 14:04 CEST Version of Record https://www.mdpi.com/1424-8247/14/5/449/pdf-vor
article xml file uploaded 19 May 2021 12:12 CEST Original file -
article xml uploaded. 19 May 2021 12:12 CEST Update https://www.mdpi.com/1424-8247/14/5/449/xml
article pdf uploaded. 19 May 2021 12:12 CEST Updated version of record https://www.mdpi.com/1424-8247/14/5/449/pdf
article html file updated 19 May 2021 12:14 CEST Original file -
article html file updated 20 May 2021 09:58 CEST Update -
article html file updated 26 July 2022 18:45 CEST Update https://www.mdpi.com/1424-8247/14/5/449/html
Back to TopTop